Hints and tips:
...“Bottom line is that it is always better as a nation to have your own oil,” said Amy Myers Jaffe, a professor at NYU....
...Results: Anglo American Q3 production report, Alphabet Q3, Archer-Daniels-Midland Q3, ASM International Q3, Barclays Q3, Brown & Brown Q3, Bunzl Q3 trading statement, Coca-Cola Company Q3, Corning Q3, Dow...
...He joins from O’Melveny & Myers. Law firm Simpson Thacher & Bartlett has named 32 new partners.* Law firm White & Case has named 42 new partners....
...Additional reporting by Daniel Thomas...
...He was shepherded by Daniel Faraci, a consultant, who recalled a particular affinity with FreedomWorks, the advocacy group that grew out of the Tea Party and was led by former House majority leader Dick...
...Superheroes aside, singular green shoots have bloomed too with cosmic screwball epic Everything Everywhere All At Once, co-directed by Dan Kwan and Daniel Scheinert....
...Additional reporting by Daniel Thomas in London...
...Ginny Myers Sain plunges the reader into deepest Louisiana for Dark and Shallow Lies (Electric Monkey, £8.99), a murky tale of murder in the swamps....
...But Amy Myers Jaffe, a professor at Tufts University’s Fletcher School, says Saudi Arabia should beware of taking that position for granted....
...The chief executive of Bristol-Myers Squibb described the US government’s support for waiver as “very concerning” during an interview at the FT US Pharma and Biotech Summit on Thursday....
...Mr Biden “is a realist”, said Daniel Yergin, vice-chairman of IHS Markit and author of The New Map....
...Early last year Bristol-Myers Squibb purchased Celgene for $93bn, while Pfizer snapped up Array BioPharma for $11bn in June....
...Advisers on the Bristol-Myers Squibb and Celgene tie-up scored one of the most lucrative advisory assignments ever recorded on Wall Street with a $1bn fee bonanza....
...Bristol-Myers Squibb last week agreed to a $90bn deal to buy Celgene, a biotech company with a deep portfolio of cancer-focused assets....
...Goldman Sachs (which found itself left out of both the AbbVie and Bristol-Myers deals) was in the clear lead at the end of Monday....
...Stefan Povaly and Daniel Rudnicki will co-run leveraged finance origination at the bank. Bruno Villard has been named head of M&A for BNP Paribas, covering Emea, Reuters reports....
...The best example is Bristol-Myers Squibb’s $90bn (agreed) deal to acquire rival drugmaker Celgene....
...BlackRock, Steven Cohen, Daniel Loeb and others are following, reports the FT’s Joshua Chaffin....
...but not yet spent or committed to deals — at end-2018 The recruitment strategy and the revenue gains fed off each other, allowing Kirkland to penetrate big M&A — advising on recent deals such as Bristol-Myers...
...“What defined the year was the mega-IPO — deals greater than $1bn,” said Liz Myers, global head of equity capital markets at JPMorgan....
...This should present no obstacle to Juliet (Claire Goose) and Nick (Daon Broni), who are church-goers, but is more problematic for secular Jewish parents Simone (Dorothea Myer-Bennett) and Sam (Daniel Lapaine...
...In the dying days of 2018, GlaxoSmithKline announced it was buying Tesaro for $5.1bn; just three days into this year Bristol-Myers Squibb said it would acquire Celgene in an eye-watering $90bn deal and...
...Belonging: The Story of the Jews 1492—1900 , by Simon Schama, Bodley Head, RRP£25/Ecco, RRP$39.99, 800 pages David N Myers is president and chief executive of the Center for Jewish History in New York,...
...More than 15 imported drugs have been approved this year, including Bristol-Myers Squibb’s Opdivo in June, Merck’s Keytruda last month and Roche’s Alecensa this month, all part of a generation of immunotherapy...
...There was no Energy Source last week because I was on holiday, and I missed the chance to discuss this thought-provoking post on Axios by Richard Newell and Daniel Raimi of Resources for the Future....
International Edition